GRCE
Grace Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GRCE Filings
Filing Date
Form Description
Form Type
2025-11-17
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2025-11-17 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-23
Form 8-K - Current report
Key Events
2025-10-23 · Key Events
Form 8-K - Current report
2025-09-18
Form 8-K - Current report
Key Events
2025-09-18 · Key Events
Form 8-K - Current report
2025-09-12
Form 8-K - Current report
Key Events
2025-09-12 · Key Events
Form 8-K - Current report
2025-08-27
Form 8-K - Current report
Key Events
2025-08-27 · Key Events
Form 8-K - Current report
2025-08-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-12
Form 8-K - Current report
Key Events
2025-08-12 · Key Events
Form 8-K - Current report
